Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ufsa Pharmaceutical Industry and Trade (Ufsa İlaç) is a prominent Turkish pharmaceutical company and a key subsidiary of Bilim Pharmaceuticals, one of the largest domestic drug manufacturers in Turkey. The company specializes in the production, marketing, and distribution of a wide array of generic pharmaceutical products across diverse therapeutic areas, including anti-infectives, cardiovascular health, and central nervous system disorders. Ufsa operates modern manufacturing facilities that adhere to international quality standards, including European Union Good Manufacturing Practice (EU-GMP). By focusing on high-quality generic alternatives, the company plays a vital role in increasing the accessibility and affordability of essential medicines within the Turkish healthcare market and various export regions. Ufsa leverages the extensive research and development and distribution infrastructure of its parent group to maintain a competitive presence in the pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ufsa Pharmaceutical Industry and Trade.